|Articles|May 15, 2002
Growth is forecast: Alcon IPO raises $2.5 billion in partial Nestle divestiture
Fort Worth, TX-Alcon Inc.'s successful initial public offering (IPO) not only confirms the stability of the company, but positions it well for future growth and investment, according to company officials and analysts.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
2
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
3
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
4
AAO 2025: The evolution of eye care on display at AAO 2025
5